Lataa...
Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail
The GL261 cell line, syngeneic on the C57BL/6 background, has, since its establishment half a century ago in 1970, become the most commonly used immunocompetent murine model of glioblastoma. As immunotherapy has entered the mainstream of clinical discourse in the past decade, this model has proved i...
Tallennettuna:
| Julkaisussa: | Neurooncol Adv |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209580/ https://ncbi.nlm.nih.gov/pubmed/34151268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab066 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|